Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03657849 · ClinicalTrials.gov registry record · NA
Evaluation of 19-gauge vs 21-gauge EBUS TBNA in Assessing Thoracic Lymphadenopathy
A NA study of Enlarged Lymph Nodes (Excluding Infective), sponsored by HealthPartners Institute.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT03657849 is a NA study of Enlarged Lymph Nodes (Excluding Infective) that has completed, run by HealthPartners Institute. The registered enrollment target is 60 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03657849, a NA study of Enlarged Lymph Nodes (Excluding Infective), has completed, sponsored by HealthPartners Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
This study compares the yield of 19-gauge needles vs 21-gauge needles during EBUS TBNA procedures.
Conditions Studied
Interventions
- DEVICE EBUS TBNA
Study Locations (1)
Minnesota
- Regions Hospital - Saint Paul
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2018-07-18 |
| Est. Completion | 2019-08-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03657849
The ClinicalTrials.gov registry entry for NCT03657849 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is HealthPartners Institute, which has 146 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Enlarged Lymph Nodes (Excluding Infective) appearing as the primary indexed condition, and to 1 intervention - of which EBUS TBNA is the first listed.
NCT03657849 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT03657849 about?
NCT03657849 is a clinical study titled "Evaluation of 19-gauge vs 21-gauge EBUS TBNA in Assessing Thoracic Lymphadenopathy". This study compares the yield of 19-gauge needles vs 21-gauge needles during EBUS TBNA procedures.
What is the current status of trial NCT03657849?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2018-07-18. Estimated completion is 2019-08-31.
What conditions does trial NCT03657849 study?
This clinical trial studies the following conditions: Enlarged Lymph Nodes (Excluding Infective).
What interventions are being tested in trial NCT03657849?
The interventions under investigation include: EBUS TBNA (DEVICE).
Who is sponsoring clinical trial NCT03657849?
This trial is sponsored by HealthPartners Institute, which has 146 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03657849 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.